- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07905794
Development of a Body Hygiene Assessment Scale for Bedbound Individuals
Development of a Body Hygiene Status Assessment Scale for Bedbound Individuals
This study aims to develop a valid and reliable assessment scale for evaluating body hygiene status in bedbound individuals. Maintaining body hygiene is an essential component of nursing care, particularly for patients who depend on others for daily activities.
The study is designed as a methodological study involving sequential qualitative and quantitative phases. Initially, semi-structured interviews will be conducted with intensive care nurses experienced in providing hygiene care to bedbound patients. The findings, together with relevant literature, will inform the development of an initial item pool.
Following item development and preliminary evaluation, the draft scale will be tested in at least 100 bedbound patients. Further psychometric evaluation will be conducted using a sample size determined according to the final number of scale items.
Body hygiene status will be assessed through observation during routine nursing care. No experimental treatment, invasive procedure, or additional medical intervention will be performed. The study aims to provide a standardized instrument to support the assessment of body hygiene status in bedbound individuals.
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
This methodological study aims to develop the Body Hygiene Status Assessment Scale for Bedbound Individuals and evaluate its validity and reliability. The study will be conducted at Bolu Izzet Baysal State Hospital, Türkiye, using sequential qualitative and quantitative phases.
**Phase 1: Qualitative Exploration and Item Development**
Individual semi-structured interviews will be conducted with approximately 10-15 intensive care nurses experienced in providing hygiene care to bedbound patients. Interviews will explore relevant anatomical regions, observable indicators of hygiene status, and nurses' professional experiences. Each interview is expected to last approximately 20-30 minutes, and interviews will continue until data saturation is reached. Findings from the qualitative phase and relevant literature will inform the development of the initial item pool.
**Phase 2: Preliminary Evaluation**
The draft scale will undergo preliminary evaluation to assess the clarity and feasibility of its items before pilot testing.
**Phase 3: Pilot Testing**
The pilot study will include at least 100 bedbound individuals meeting the eligibility criteria. Exploratory factor analysis and item analyses will be performed to examine the factor structure, refine the items, and determine the final number of scale items.
**Phase 4: Main Psychometric Evaluation**
Confirmatory factor analysis will be conducted in an independent sample that does not include participants from the pilot study. The main study sample size will be determined based on at least 10 participants per final scale item. The validity and reliability of the developed scale will be evaluated.
**Informed Consent and Participant Safety**
Written informed consent will be obtained directly from patients with decision-making capacity. For patients unable to provide informed consent, written consent will be obtained from their legally authorized representatives.
Body hygiene status will be assessed through direct observation during routine nursing care and hygiene procedures, only when the relevant anatomical regions are already visible. No additional exposure of body regions, invasive procedures, experimental treatments, or interventions beyond routine care will be performed. Patient privacy, comfort, and confidentiality will be maintained throughout the study.
The scale development process will be informed by contemporary measurement development principles and relevant COSMIN recommendations.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Saadet Can Çiçek, PhD
- Telefonnummer: +90 506 284 69 36
- E-Mail: saadet.cancicek@ibu.edu.tr
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
The study population will include intensive care nurses experienced in providing hygiene care to bedridden patients and adult bedridden inpatients. Nurses will participate in the qualitative phase to inform the development of scale items. Bedridden patients will participate in the subsequent pilot testing and psychometric validation of the scale.
Beschreibung
Inclusion Criteria:
Qualitative Phase (Nurses):
- Aged 18 years or older.
- Intensive care nurses experienced in providing hygiene care to bedridden patients.
- Voluntary participation in individual interviews.
Scale Development and Validation Phase (Patients):
- Aged 18 years or older.
- Bedridden patients receiving inpatient care.
- Eligible for hygiene assessment during routine nursing care.
Exclusion Criteria:
- Not meeting the inclusion criteria for the relevant study phase.
- Declining participation or withdrawing consent, where applicable.
- Any additional exclusion criteria specified in the approved study protocol.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: OTHER
- Zeitperspektiven: PROSPECTIVE
Kohorten und Interventionen
Gruppe / Kohorte |
|---|
|
Qualitative Interview Group
Approximately 10-15 intensive care nurses experienced in providing hygiene care to bedbound patients will participate in individual semi-structured interviews. The findings will inform the development of the initial scale item pool. |
|
Pilot Psychometric Evaluation Group
At least 100 bedbound patients meeting the eligibility criteria will be assessed using the draft Body Hygiene Status Assessment Scale. Exploratory factor analysis and item analyses will be performed to examine the preliminary factor structure and refine the scale items. |
|
Main Psychometric Validation Group
An independent sample of bedbound patients, excluding participants from the pilot study, will be evaluated using the refined Body Hygiene Status Assessment Scale. The sample size will be determined based on at least 10 participants per final scale item. Confirmatory factor analysis and reliability analyses will be conducted to evaluate the psychometric properties of the scale. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Construct Validity of the Body Hygiene Status Assessment Scale
Zeitfenster: At the single study assessment (baseline), conducted once during routine nursing care.
|
The construct validity of the Body Hygiene Status Assessment Scale will be evaluated using exploratory factor analysis (EFA) in a pilot sample of at least 100 bedridden patients and confirmatory factor analysis (CFA) in an independent validation sample. The scale currently consists of 10 items, each scored from 0 to 2, yielding a preliminary total score range of 0-20. Higher scores indicate better body hygiene status, whereas lower scores indicate poorer body hygiene status. Factor loadings, model fit indices, and the resulting factor structure will be examined. |
At the single study assessment (baseline), conducted once during routine nursing care.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Internal Consistency Reliability of the Body Hygiene Status Assessment Scale
Zeitfenster: One assessment per participant during routine nursing care and hygiene procedures.
|
Internal consistency reliability of the Body Hygiene Status Assessment Scale will be evaluated using Cronbach's alpha coefficient and item-total correlations. Reliability estimates will be calculated using data obtained from bedridden individuals assessed with the developed scale. Higher Cronbach's alpha values indicate greater internal consistency. |
One assessment per participant during routine nursing care and hygiene procedures.
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Saadet Can Çiçek, Assoc. Prof., PhD, Abant Izzet Baysal University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- AIBU- SBF- NDS- 2026
- 2026/427 (Andere Kennung: Bolu Abant Izzet Baysal University Non-Interventional Clinical Research Ethics Committee)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Individual participant data will not be publicly shared due to participant confidentiality and data protection considerations.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .